900
Participants
Start Date
May 16, 2024
Primary Completion Date
June 16, 2025
Study Completion Date
November 16, 2025
VIDAS® TBI Test [GFAP and UCH-L1 assays]
The VIDAS® TBI (GFAP, UCH-L1) test is composed of two automated assays - VIDAS® TBI (GFAP) and VIDAS® TBI (UCH-L1) - to be used on the VIDAS® family of instruments for the quantitative measurement of Glial 15 Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase- L1 (UCH-L1) in human serum using the Enzyme Linked Fluorescent Assay (ELFA) technique. The results of both assays are required to obtain an overall qualitative test interpretation.
RECRUITING
University of Rochester, Rochester
RECRUITING
Orlando Health, Orlando
RECRUITING
Wayne State University, Detroit
RECRUITING
Mayo Clinic, Rochester
RECRUITING
Washington University, St Louis
Lead Sponsor
BioMérieux
INDUSTRY